In this study, although the majority of Pfizer and Sinopharm-vaccinated groups did not have previous infection with SARS-CoV-2 (Table 1), 25% (25/100) and 48% (48/100) of participants showed anti-N Abs in their sera, respectively. This evidence concerns the gene DDX41 and infection.